Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Laura C. Michaelis"'
Autor:
Chandrasekar Muthiah, Qinghua Lian, Samantha Benz, Aniko Szabo, Karin Hoffmeister, Juliana Perez Botero, Laura C. Michaelis
Publikováno v:
Haematologica, Vol 109, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/01158b95f88e403e96815539bf0c516a
Autor:
Scott R. Solomon, Bayard L. Powell, Jamie Koprivnikar, Catherine Lai, Heather Male, Laura C. Michaelis, Laura F. Newell, David Sanford, Jack Jenkins, Amy Zelaya, Sheryl Coppola, Stefan Faderl, Roland B. Walter
Publikováno v:
Cancers, Vol 16, Iss 5, p 915 (2024)
This open-label phase 1 study (clinicaltrials.gov, NCT03555955) assessed CPX-351 pharmacokinetics (PK) and safety in patients with hematologic malignancies with normal or impaired renal function. Patients were enrolled into three cohorts based on the
Externí odkaz:
https://doaj.org/article/a32abb183e3b4fcca91ced09b2af1728
Autor:
Philip C. Berce, PharmD, Leah Cardwell, MD, Amber N. Essenmacher, PA-C, Laura C. Michaelis, MD, Karolyn A. Wanat, MD
Publikováno v:
JAAD Case Reports, Vol 22, Iss , Pp 110-113 (2022)
Externí odkaz:
https://doaj.org/article/59f0c1c44e214b64b1060ffab2feeef7
Autor:
Laura C. Michaelis
Publikováno v:
Haematologica, Vol 102, Iss 1 (2017)
Externí odkaz:
https://doaj.org/article/8388ecb1f8634d5b83c6853fe8f00f68
Autor:
Tamara K. Moyo, Ashwin Kishtagari, Matthew T. Villaume, Brandon McMahon, Sanjay R. Mohan, Tess Stopczynski, Sheau-Chiann Chen, Run Fan, Yuankai Huo, Hyeonsoo Moon, Yucheng Tang, Cosmin A. Bejan, Merrida Childress, Ingrid Anderson, Kyle Rawling, Rhea M. Simons, Ashley Moncrief, Rebekah Caza, Laura Dugger, Aunshka Collins, Channing V. Dudley, P. Brent Ferrell, Michael Byrne, Stephen A. Strickland, Gregory D. Ayers, Bennett A. Landman, Emily F. Mason, Ruben A. Mesa, Jeanne M. Palmer, Laura C. Michaelis, Michael R. Savona
Publikováno v:
Clinical Cancer Research. :OF1-OF10
Purpose: Treatment options are limited beyond JAK inhibitors for patients with primary myelofibrosis (MF) or secondary MF. Preclinical studies have revealed that PI3Kδ inhibition cooperates with ruxolitinib, a JAK1/2 inhibitor, to reduce proliferati
Autor:
Yaping Chang, Gordon H Guyatt, Trevor Teich, Jamie L Dawdy, Shaneela Shahid, Jessica K Altman, Richard M Stone, Mikkael A Sekeres, Sudipto Mukherjee, Thomas W LeBlanc, Gregory A Abel, Christopher S Hourigan, Mark R Litzow, Laura C Michaelis, Shabbir M H Alibhai, Pinkal Desai, Rena Buckstein, Janet MacEachern, Romina Brignardello-Petersen
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0249087 (2021)
To compare the effectiveness and safety of intensive antileukemic therapy to less-intensive therapy in older adults with acute myeloid leukemia (AML) and intermediate or adverse cytogenetics, we searched the literature in Medline, Embase, and CENTRAL
Externí odkaz:
https://doaj.org/article/cb2e4ee8a8d8462e86a8fcc1f73eb6e0
Autor:
Michael R. Savona, Laura C. Michaelis, Jeanne M. Palmer, Ruben A. Mesa, Emily F. Mason, Bennett A. Landman, Gregory D. Ayers, Stephen A. Strickland, Michael Byrne, P. Brent Ferrell, Channing V. Dudley, Aunshka Collins, Laura Dugger, Rebekah Caza, Ashley Moncrief, Rhea M. Simons, Kyle Rawling, Ingrid Anderson, Merrida Childress, Cosmin A. Bejan, Yucheng Tang, Hyeonsoo Moon, Yuankai Huo, Run Fan, Sheau-Chiann Chen, Tess Stopczynski, Sanjay R. Mohan, Brandon McMahon, Matthew T. Villaume, Ashwin Kishtagari, Tamara K. Moyo
Supplemental Tables S1-S9 Supplemental Figures S1-S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00824c6ff87fc381e622ce00f6089201
https://doi.org/10.1158/1078-0432.22787600.v1
https://doi.org/10.1158/1078-0432.22787600.v1
Autor:
Michael R. Savona, Laura C. Michaelis, Jeanne M. Palmer, Ruben A. Mesa, Emily F. Mason, Bennett A. Landman, Gregory D. Ayers, Stephen A. Strickland, Michael Byrne, P. Brent Ferrell, Channing V. Dudley, Aunshka Collins, Laura Dugger, Rebekah Caza, Ashley Moncrief, Rhea M. Simons, Kyle Rawling, Ingrid Anderson, Merrida Childress, Cosmin A. Bejan, Yucheng Tang, Hyeonsoo Moon, Yuankai Huo, Run Fan, Sheau-Chiann Chen, Tess Stopczynski, Sanjay R. Mohan, Brandon McMahon, Matthew T. Villaume, Ashwin Kishtagari, Tamara K. Moyo
Purpose:Treatment options are limited beyond JAK inhibitors for patients with primary myelofibrosis (MF) or secondary MF. Preclinical studies have revealed that PI3Kδ inhibition cooperates with ruxolitinib, a JAK1/2 inhibitor, to reduce proliferatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66f4bf7c7d922639cc2f4c32c3e57a35
https://doi.org/10.1158/1078-0432.c.6637754.v1
https://doi.org/10.1158/1078-0432.c.6637754.v1
Autor:
Jordan R. Hanrahan, Leroy J. Seymour, Anna Beckius, Donna Welter, Mandy Kastner, Valarie Ehrlich, Kristine Broge-Reynen, Mary Rodgers, Laura C. Michaelis, Lyndsey Runaas, Ehab L. Atallah, Sameem Abedin, Guru Subramanian Guru Murthy, Ravi Kishore Narra, Mary Fournogerakis, Jessica Schmitz, Andrea Viitala, Elizabeth Larsen, Amber Essenmacher, Gina George, Kim Johnston, Karen Sue Carlson, Nicole Held
Publikováno v:
Blood. 140:5083-5085
Autor:
Sarit Assouline, Laura C. Michaelis, Megan Othus, Annette E. Hay, Roland B. Walter, Meagan A. Jacoby, Mark A. Schroeder, Geoffrey L. Uy, Lisa Y. Law, Faisal Cheema, Kendra L. Sweet, Adam S. Asch, Jijun (Jane) Liu, Anna B. Moseley, Tracy Maher, Laura L. Kingsbury, Min Fang, Jerald Radich, Richard F. Little, Harry P. Erba
Publikováno v:
Leukemialymphoma.